Tata Chemicals Ltd. delivered a muted performance in Q1FY27, with consolidated EBITDA declining 15% YoY to ₹5.6 billion, surpassing analyst estimates of ₹4.5 billion. According to Motilal Oswal's latest research report dated July 28, 2026, the muted performance was primarily driven by significant challenges in key business segments. TCNA and TCAHL witnessed sharp EBITDA declines of 98% and 94% respectively, while TCEHL reported an EBITDA loss of ₹50 million. However, the company's standalone India and Rallis businesses provided some relief with EBITDA growth of 35% and 23% respectively, demonstrating resilience in domestic operations.
Following Tata Chemicals Ltd.'s June quarter earnings, Motilal Oswal has maintained its Neutral rating on the stock with an SoTP-based target price of ₹700. According to the brokerage's analysis, the near-term environment remains challenging, with the soda ash demand-supply balance yet to meaningfully improve despite expectations of future demand from solar glass and electric vehicles. As reported by NDTV Profit, benefits from these end-use industries are likely to play out gradually, while the current oversupply persists in the market. The latest research report reinforces this cautious outlook while acknowledging the company's strategic diversification efforts.
The Indian standalone business is expected to continue delivering healthy performance on the back of resilient domestic demand, stable pricing, and growth-focused capital allocation toward the non-cyclical business, according to Motilal Oswal. According to the brokerage's report, this domestic strength provides a solid foundation for the company's overall performance despite challenges in international markets. The company's expansion plans in India are expected to support this growth trajectory, though the payoff remains contingent on a broader cyclical recovery. The latest quarterly results demonstrate this domestic resilience with strong EBITDA growth of 35% in the standalone India business.
Diversification from the commodity business (primarily soda ash) to the specialty segment/batteries is expected to pay off for Tata Chemicals in the medium-to-long run, as noted by Motilal Oswal. The brokerage expects the company to record a revenue/EBITDA compound annual growth rate of 10%/27% over FY26-28. This strategic shift toward specialty chemicals and batteries represents a key component of the company's growth strategy, though the benefits are expected to materialize gradually as the diversification efforts mature. The latest quarterly performance shows the company's commitment to this diversification through its focus on non-cyclical businesses.
Despite the positive outlook for India operations, Motilal Oswal acknowledges that the company's expansion plans in India are contingent on a broader cyclical recovery, limiting near-term upside potential. According to the brokerage's analysis, while the company's diversification strategy shows promise, the current oversupply situation in the soda ash market continues to create headwinds for international operations. The gradual nature of benefits from new end-use industries like solar glass and electric vehicles further supports the cautious near-term outlook. The latest quarterly results reflect this challenging international environment with significant declines in key segments.
